DaShenLin Pharmaceutical Group Co., Ltd

Short Term Long Term Short Term Comparison Long Term Comparison
  • 603233
  • 1d5.42%
  • 1w2.23%
  • 1m-0.77%
  • 1y-27.83%
ATH
  • ATH Price$57.53
  • ATH Date2021-01-25
  • % since ATH-61.80%
  • % to ATH161.75%
ATL
  • ATL Price$12.11
  • ATL Date2017-07-31
  • % from ATL81.50%
  • Last Low Price$15.8097
  • Last Low Date2022-04-26
  • % From Last Low39.03%
IPO
  • IPO Price$29.66
  • % Current ROI USD-25.89%
  • ATH Price$57.53
  • % ROI ATH 47,507.76%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="603233"]

Key Data [addtoany]

Current price $21.98
Sector Healthcare
Industry Biotechnology
Today's High/Low $22.2/$20.8
Volume 13,912,330.00
Previous Close $20.85
52 Week High/Low $30.3595/$20.7
Market Cap 23,745,024,000.00
P/E Ratio 18.4513
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $1.42
Annualized Dividend $0.0288
$21.98
[addtoany]

DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. The company was founded in 1999 and is based in Guangzhou, China.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity